Zenrin Co., Ltd.

As of March 31, 2025, Zenrin Co., Ltd. carries a market capitalization of 56.63B, placing it among publicly traded companies globally. Its enterprise value stands at 45.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Zenrin Co., Ltd.'s next confirmed earnings release is scheduled for October 29, 2026.

As of March 31, 2025, Zenrin Co., Ltd. has 53.38M shares outstanding.

These figures are as of March 31, 2025.

As of March 31, 2025, Zenrin Co., Ltd. maintains a current ratio of 1.36, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2025.

Over the twelve months ended March 31, 2025, Zenrin Co., Ltd. recorded 1.53B in income tax expense.

As of the close on October 22, 2026, Zenrin Co., Ltd.'s stock has declined approximately 15.32% over the past 52 weeks. The 50-day moving average sits at 905.66, while the 200-day moving average is 942.92.

As of March 31, 2025, Zenrin Co., Ltd. holds 13.92B in cash and equivalents against 2.81B in total debt, resulting in a net debt position of -11.56B. Total book value stands at 49.83B, with working capital of 7.64B providing operational flexibility.

Zenrin Co., Ltd.'s most recent stock split took place on March 28, 2018 with a 2:3 split ratio.